Man Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$248K Buy
+16,968
New +$164K ﹤0.01% 2227
2025
Q3
Sell
-92,682
Closed -$678K 2380
2025
Q2
$678K Buy
92,682
+67,050
+262% +$541K ﹤0.01% 1734
2025
Q1
$243K Buy
+25,632
New +$320K ﹤0.01% 1987
2021
Q4
Sell
-101,272
Closed -$4.88M 2055
2021
Q3
$4.88M Buy
101,272
+3,799
+4% +$176K 0.02% 844
2021
Q2
$4.4M Buy
97,473
+1,787
+2% +$79.2K 0.02% 943
2021
Q1
$4.62M Buy
95,686
+5,682
+6% +$296K 0.02% 724
2020
Q4
$4.85M Sell
90,004
-57,563
-39% -$2.6M 0.02% 830
2020
Q3
$5.44M Buy
147,567
+56,258
+62% +$2.09M 0.02% 767
2020
Q2
$2.83M Buy
91,309
+49,541
+119% +$1.37M 0.01% 921
2020
Q1
$1.15M Sell
41,768
-9,683
-19% -$290K 0.01% 1074
2019
Q4
$1.5M Buy
+51,451
New +$1.23M ﹤0.01% 1406
2019
Q3
Sell
-131,797
Closed -$2.89M 1869
2019
Q2
$2.89M Buy
131,797
+121,900
+1,232% +$2.67M 0.01% 1174
2019
Q1
$203K Buy
+9,897
New +$172K ﹤0.01% 1878
2018
Q4
Sell
-21,074
Closed -$323K 2049
2018
Q3
$323K Buy
21,074
+9,873
+88% +$136K ﹤0.01% 1933
2018
Q2
$147K Buy
+11,201
New +$123K ﹤0.01% 2049

Other funds holding NEO

Man Group's NEO Position: Q2 2026 in Review

Man Group opened a new position in NeoGenomics (NEO) in Q2 2026: 16,968 shares worth $248K. The stake represents ﹤0.01% of the portfolio and ranks #2227 among its holdings. This is a return to the name: Man Group previously reported a position in NEO as recently as Q2 2025.

Man Group first reported a position in NEO in Q2 2018 and has held it in 15 quarters since. The position peaked at $5.44M in Q3 2020. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Man Group held 16,968 shares of NeoGenomics worth $248K as of Q2 2026.
  • NeoGenomics was a new Man Group position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2227 holding.
  • Man Group first reported a position in NeoGenomics in Q2 2018 and has held it in 15 quarters since.
  • Man Group's NeoGenomics position peaked at $5.44M in Q3 2020.
  • 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.